Shattuck Labs Inc
NASDAQ:STTK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shattuck Labs Inc
NASDAQ:STTK
|
US |
|
AN2 Therapeutics Inc
NASDAQ:ANTX
|
US |
|
Applovin Corp
NASDAQ:APP
|
US |
|
APG SGA SA
SIX:APGN
|
CH |
|
D
|
Draganfly Inc
CNSX:DPRO
|
CA |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
J
|
JOYY Inc
XHAM:0YYA
|
SG |
|
C
|
Coca Cola HBC AG
OTC:CCHBF
|
CH |
|
L
|
Laurent Perrier SA
OTC:LPRRF
|
FR |
|
CAR Inc
HKEX:699
|
CN |
|
SoftBank Corp
TSE:9434
|
JP |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Hindcon Chemicals Ltd
NSE:HINDCON
|
IN |
|
Azelis Group NV
XBRU:AZE
|
BE |
|
Ted Baker PLC
LSE:TED
|
UK |
|
Karoon Energy Ltd
ASX:KAR
|
AU |
|
Synaptics Inc
NASDAQ:SYNA
|
US |
|
N
|
Neschen AG
F:NSN
|
DE |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
Mitek Systems Inc
NASDAQ:MITK
|
US |
|
Fortescue Metals Group Ltd
ASX:FMG
|
AU |
|
A
|
Aegon NV
NYSE:AEG
|
NL |
|
Fosterville South Exploration Ltd
XTSX:FSX
|
CA |
|
Sanlorenzo SpA
MIL:SL
|
IT |
Bankruptcy Probability
Shattuck Labs Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shattuck Labs Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Shattuck Labs Inc
NASDAQ:STTK
|
449.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shattuck Labs Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shattuck Labs Inc has no debt.
You can find a full breakdown on its Balance Sheet.
